BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29099240)

  • 1. Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference.
    Phan AQ; Pacifici M; Esko JD
    Connect Tissue Res; 2018 Jan; 59(1):85-98. PubMed ID: 29099240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research.
    Jones KB; Pacifici M; Hilton MJ
    Connect Tissue Res; 2014 Apr; 55(2):80-8. PubMed ID: 24409815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palovarotene Inhibits Osteochondroma Formation in a Mouse Model of Multiple Hereditary Exostoses.
    Inubushi T; Lemire I; Irie F; Yamaguchi Y
    J Bone Miner Res; 2018 Apr; 33(4):658-666. PubMed ID: 29120519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses.
    Matsumoto K; Irie F; Mackem S; Yamaguchi Y
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10932-7. PubMed ID: 20534475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses.
    Mundy C; Chung J; Koyama E; Bunting S; Mahimkar R; Pacifici M
    J Orthop Res; 2022 Oct; 40(10):2391-2401. PubMed ID: 34996123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary Multiple Exostoses: New Insights into Pathogenesis, Clinical Complications, and Potential Treatments.
    Pacifici M
    Curr Osteoporos Rep; 2017 Jun; 15(3):142-152. PubMed ID: 28466453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern.
    Beltrami G; Ristori G; Scoccianti G; Tamburini A; Capanna R
    Clin Cases Miner Bone Metab; 2016; 13(2):110-118. PubMed ID: 27920806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unsuspected osteochondroma-like outgrowths in the cranial base of Hereditary Multiple Exostoses patients and modeling and treatment with a BMP antagonist in mice.
    Sinha S; Mundy C; Bechtold T; Sgariglia F; Ibrahim MM; Billings PC; Carroll K; Koyama E; Jones KB; Pacifici M
    PLoS Genet; 2017 Apr; 13(4):e1006742. PubMed ID: 28445472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSPG-deficient zebrafish uncovers dental aspect of multiple osteochondromas.
    Wiweger MI; Zhao Z; van Merkesteyn RJ; Roehl HH; Hogendoorn PC
    PLoS One; 2012; 7(1):e29734. PubMed ID: 22253766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
    Pacifici M
    Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling systems affecting the severity of multiple osteochondromas.
    Piombo V; Jochmann K; Hoffmann D; Wuelling M; Vortkamp A
    Bone; 2018 Jun; 111():71-81. PubMed ID: 29545125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal scarring with keloid formation after osteochondroma excision in children with multiple hereditary exostoses.
    Hosalkar H; Greenberg J; Gaugler RL; Garg S; Dormans JP
    J Pediatr Orthop; 2007; 27(3):333-7. PubMed ID: 17414021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple osteochondromas.
    Bovée JV
    Orphanet J Rare Dis; 2008 Feb; 3():3. PubMed ID: 18271966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary multiple exostoses: are there new plausible treatment strategies?
    Pacifici M
    Expert Opin Orphan Drugs; 2018; 6(6):385-391. PubMed ID: 31448184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Multiple Exostoses: Current Insights.
    D'Arienzo A; Andreani L; Sacchetti F; Colangeli S; Capanna R
    Orthop Res Rev; 2019; 11():199-211. PubMed ID: 31853203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses.
    Huegel J; Sgariglia F; Enomoto-Iwamoto M; Koyama E; Dormans JP; Pacifici M
    Dev Dyn; 2013 Sep; 242(9):1021-32. PubMed ID: 23821404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Multiple Exostoses-A Review of the Molecular Background, Diagnostics, and Potential Therapeutic Strategies.
    Bukowska-Olech E; Trzebiatowska W; Czech W; Drzymała O; Frąk P; Klarowski F; Kłusek P; Szwajkowska A; Jamsheer A
    Front Genet; 2021; 12():759129. PubMed ID: 34956317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shop talk: Sugars, bones, and a disease called multiple hereditary exostoses.
    Roehl HH; Pacifici M
    Dev Dyn; 2010 Jun; 239(6):1901-4. PubMed ID: 20503385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Hereditary Exostoses: Report of an
    Camacho J; Gutierrez LD; Rubio C; Suárez A; Amaya A
    J Pediatr Genet; 2018 Sep; 7(3):122-124. PubMed ID: 30105120
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.